1/29
10:58 am
nyxh
Nyxoah (NASDAQ:NYXH) was given a new $11.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
Low
Report
Nyxoah (NASDAQ:NYXH) was given a new $11.00 price target on by analysts at Stifel Nicolaus. They now have a "buy" rating on the stock.
1/21
04:05 pm
nyxh
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
Low
Report
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
1/12
04:05 pm
nyxh
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
Low
Report
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
1/12
01:00 am
nyxh
Publication relating to transparency notification
Low
Report
Publication relating to transparency notification
12/19
04:05 pm
nyxh
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
Low
Report
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
12/17
01:05 am
nyxh
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
Low
Report
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
12/2
04:30 pm
nyxh
Publication relating to transparency notifications
Low
Report
Publication relating to transparency notifications
11/27
04:05 pm
nyxh
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/26
01:45 am
nyxh
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
Low
Report
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
11/20
04:30 pm
nyxh
Information on the total number of voting rights and shares
Low
Report
Information on the total number of voting rights and shares
11/14
09:05 am
nyxh
Nyxoah (NASDAQ:NYXH) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Nyxoah (NASDAQ:NYXH) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
11/13
07:30 pm
nyxh
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
Medium
Report
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio